Thermo Fisher Scientific (NYSE: TMO) Q1 Earnings Review: Revenue Growth Amidst EPS Miss

Thermo Fisher Scientific (NYSE: TMO) reported Q1 GAAP diluted EPS of $4.43, falling short of the analyst consensus estimate of $5.20.
Despite the EPS miss, the company's Q1 revenue reached $11.01 billion, surpassing the estimated $10.86 billion, driven by strong performance in laboratory products and biopharma services.
The company demonstrates strong financial health with a debt-to-equity ratio of 0.83 and a current ratio of 1.53, indicating a solid ability to manage short-term obligations.

Thermo Fisher Scientific (NYSE: TMO) is a company that supplies scientific instruments, lab products, and services. Its business includes divisions for laboratory products, biopharma services, analytical instruments, and specialty diagnostics. The company aims for growth by launching new products, such as its next-generation microscopes for research.

On April 23, 2026, Thermo Fisher Scientific reported its first-quarter earnings results. The company announced a GAAP diluted earnings per share (EPS) of $4.43. This figure missed the analyst consensus estimate of $5.20, as highlighted by Zacks. EPS is a measure of a company's profit allocated to each outstanding share of stock.

In contrast to its earnings, Thermo Fisher Scientific's revenue for the quarter surpassed expectations. The company reported revenue of $11.01 billion, which was higher than the estimated $10.86 billion. As highlighted by Reuters, this performance was due to growth in its laboratory products and biopharma services business.

Looking at the company's valuation, Thermo Fisher Scientific has a trailing price-to-earnings (P/E) ratio of 25.32. The P/E ratio shows what investors are willing to pay for each dollar of a company's earnings. The company also has a price-to-sales ratio of 3.84, which compares the stock price to its revenues.

From a financial health perspective, Thermo Fisher Scientific maintains a debt-to-equity ratio of 0.83. The company also has a current ratio of 1.53. The current ratio is a key indicator of a company's ability to pay its short-term debts, with a value above 1 generally seen as positive.